OptiLight by Lumenis, A Bright Solution for Dry Eyes
[Porter Ranch, California, December, 2022] – Avant Eyes Optometry today announced the expansion of their dry eye management options to include OptiLight by Lumenis, a light-based treatment.
Dry eye is a common disease, with up to 49 million suffering from it in the US alone. This disease can have a significant impact on quality of life, leading to a foreign body sensation in the eyes, pain, blurry vision, and dry or watery eyes.
OptiLight by Lumenis is a light-based, non-invasive treatment done in the area below the eyes that addresses many of the key factors in dry eye disease: inflammation, tear break-up time, and meibomian gland functionality. The first and only IPL FDA-approved for dry eye management.
One OptiLight appointment lasts approximately 10–15 minutes. The treatment is safe, gentle, and effective with no downtime, typically allowing the patient to return to their daily activities straight away.
“Dry Eye Disease can be debilitating and really affect quality of life and vision. We are excited to have an effective, non-surgical treatment solution to finally help our patients,” said Dr. Hardeep Kataria, founder of Avant Eyes Optometry.
Avant Eyes Optometry is dedicated to its patient’s health by providing personalized care that is delivered with advanced technology that goes beyond industry standards. The team highly values the personal relationships they curate with their patients, so each visit is tailored to their specific needs. Using modern technology and staying up-to-date on advanced treatments is part of their commitment to caring for everyone who walks through their door.
If you would like more information on Avant Eyes Optometry’s dry eye solutions, please call 818-900-5650.